Report Details

Product Image
Healthcare & Pharmaceuticals

Global mHealth Market Research Report, 2020–2040

$2999

Explore the global mHealth market size, share, trends, growth drivers, segmentation, competitive landscape, and forecast through 2034.

SKU: GDRA-MHEALTH-2026-00    Pages: 997   Format: PDF   Delivery: Upto 24 to 48 hrs

Global mHealth Market Overview

  • The Global mHealth Market was valued at USD 120,852.77 million in 2025 and is projected to reach USD 801,216.49 million by 2040, expanding at a compound annual growth rate of 13.44% from 2025 to 2040.
  • The Global mHealth Market is growing due to increasing smartphone penetration, rising adoption of mobile healthcare applications, expanding use of connected medical devices, and growing demand for remote patient monitoring and virtual healthcare services.
  • The Global mHealth Market report provides detailed analysis by offering, application type, connected device form factor, monitoring function, clinical use case, therapeutic area, user, customer type, care setting, deployment model, revenue model, connectivity technology, and region.

Global mHealth Market Segmentation

By Offering

  • mHealth Applications and Software
  • Connected mHealth Devices
  • mHealth Services

By mHealth Application Type

  • Medical and Clinical Applications
  • Wellness and Preventive Health Applications

By Connected Device Form Factor

  • Wearable Devices
  • Handheld and Portable Devices
  • Smartphone- and Tablet-Connected Accessories
  • Connected Home Health Devices
  • Connected Medication Management Devices
  • Connected Implantable Devices

By Monitoring and Measurement Function

  • Single-Parameter Monitoring
  • Multi-Parameter Monitoring

By Primary Clinical Use Case

  • Health Promotion and Disease Prevention
  • Risk Assessment and Early Screening
  • Diagnosis and Clinical Decision Support
  • Continuous and Intermittent Patient Monitoring
  • Treatment and Therapeutic Intervention
  • Medication Management and Adherence
  • Rehabilitation and Recovery Management
  • Post-Treatment Follow-Up
  • Patient Education and Self-Management
  • Clinical Communication and Care Coordination
  • Emergency Detection and Response
  • Public-Health Surveillance and Population Management

By Disease and Therapeutic Area

  • Cardiovascular Diseases
  • Diabetes and Metabolic Disorders
  • Respiratory Diseases
  • Mental and Behavioral Health Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal and Pain Disorders
  • Women’s and Reproductive Health
  • Renal and Urological Diseases
  • Gastrointestinal Diseases
  • Infectious Diseases
  • Dermatological Diseases
  • Ophthalmic Disorders
  • Rare Diseases
  • Other Disease and Therapeutic Areas

By Primary User

  • Patients and Consumers
  • Physicians
  • Nurses
  • Pharmacists
  • Physiotherapists and Rehabilitation Professionals
  • Behavioral and Mental Health Professionals
  • Dietitians and Nutrition Professionals
  • Caregivers and Family Members
  • Community Health Workers
  • Emergency Medical Personnel
  • Clinical Researchers
  • Healthcare Administrative Personnel

By Customer Type

  • Direct-to-Consumer Customers
  • Healthcare Providers
  • Health Insurance Companies and Payers
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Employers and Corporate Wellness Providers
  • Government and Public-Health Organizations
  • Research Institutes and Academic Organizations
  • Non-Governmental and Humanitarian Organizations

By Care Setting

  • Home-Based Care
  • Hospitals
  • Ambulatory Clinics and Physician Offices
  • Diagnostic and Imaging Centers
  • Pharmacies and Retail Health Settings
  • Rehabilitation Centers
  • Long-Term Care and Assisted-Living Facilities
  • Community and Field-Based Healthcare
  • Workplace and Corporate Health Settings
  • Emergency and Prehospital Settings

By Deployment Model

  • Cloud-Based mHealth Solutions
  • On-Device and Edge-Based mHealth Solutions
  • On-Premises Enterprise mHealth Solutions
  • Hybrid mHealth Solutions

By Delivery Model

  • Business-to-Consumer
  • Business-to-Business
  • Business-to-Business-to-Consumer
  • Government-to-Citizen

By Primary Revenue Model

  • Subscription-Based Model
  • One-Time Application or Software Licensing
  • Pay-Per-Consultation or Pay-Per-Use
  • Connected-Device Sales and Bundled Services
  • Provider-, Payer- or Employer-Sponsored Access
  • Advertising and Lead-Generation Model
  • Data Analytics and Insights Licensing
  • Public Funding and Government Contract Model

By Primary Connectivity Technology

  • Bluetooth and Bluetooth Low Energy
  • Cellular Connectivity
  • Wi-Fi
  • Near-Field Communication
  • Low-Power Wide-Area Networks
  • Satellite Connectivity
  • Multi-Connectivity Solutions

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Key Players in the Global mHealth Market

The Global mHealth Market report provides company profiles covering company details, financial performance, product portfolios, key regions of operation, major competitors, subsidiaries, and recent developments such as mergers, acquisitions, partnerships, and product launches.

Connected Devices, Wearables and Medical Monitoring Companies

  • Apple Inc.
  • Alphabet Inc. (Google/Fitbit)
  • Samsung Electronics Co., Ltd.
  • Huawei Technologies Co., Ltd.
  • Xiaomi Corporation
  • Garmin Ltd.
  • Oura Health Oy
  • WHOOP, Inc.
  • Withings
  • Zepp Health Corporation
  • Polar Electro Oy
  • Abbott Laboratories
  • Dexcom, Inc.
  • Medtronic plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Senseonics Holdings, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ypsomed Holding AG
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Boston Scientific Corporation
  • Masimo Corporation
  • OMRON Healthcare Co., Ltd.
  • iRhythm Technologies, Inc.
  • ResMed Inc.
  • ZOLL Medical Corporation
  • BioIntelliSense, Inc.
  • VitalConnect, Inc.
  • Empatica Inc.
  • Sibel Health, Inc.
  • AliveCor, Inc.
  • Eko Health, Inc.
  • Butterfly Network, Inc.
  • Clarius Mobile Health Corp.
  • TytoCare Ltd.
  • Healthy.io Ltd.
  • Binah.ai Ltd.
  • Qompium NV
  • Aktiia SA
  • Biobeat Technologies Ltd.
  • CardiacSense Ltd.
  • Corsano Health B.V.
  • SmartCardia SA
  • LifeSignals, Inc.
  • Vivalink, Inc.
  • Biofourmis, Inc.
  • Huma Therapeutics Limited
  • Current Health
  • Others

Telehealth and Mobile Virtual-Care Companies

  • Teladoc Health, Inc.
  • American Well Corporation
  • Included Health, Inc.
  • Doximity, Inc.
  • Amazon One Medical
  • Hims & Hers Health, Inc.
  • K Health, Inc.
  • HealthTap, Inc.
  • eVisit, Inc.
  • MDLIVE Inc.
  • Doctolib SAS
  • Kry International AB (Livi)
  • Docplanner Group
  • Practo Technologies Pvt. Ltd.
  • Halodoc
  • Doctor Anywhere Pte. Ltd.
  • Ping An Healthcare and Technology Company Limited
  • JD Health International Inc.
  • Alibaba Health Information Technology Limited
  • Maven Clinic Co.
  • Others

Chronic Disease Management and Digital Therapeutics Companies

  • Omada Health, Inc.
  • Virta Health Corp.
  • DarioHealth Corp.
  • Welldoc, Inc.
  • Lark Technologies, Inc.
  • Noom, Inc.
  • Hinge Health, Inc.
  • Sword Health Technologies, Inc.
  • Kaia Health Software GmbH
  • Sidekick Health
  • HelloBetter
  • Big Health Ltd.
  • Click Therapeutics, Inc.
  • Virtual Therapeutics
  • WELT Corp.
  • Others

Mental and Behavioral mHealth Companies

  • Headspace Health
  • Calm.com, Inc.
  • Talkspace, Inc.
  • Spring Health
  • Wysa Ltd.
  • Others

Remote Patient Monitoring and Care-Management Companies

  • Cadence Solutions
  • Health Recovery Solutions, Inc.
  • CoachCare
  • Validic, Inc.
  • Datos Health
  • Rimidi, Inc.
  • Luscii Healthtech B.V.
  • Doccla Ltd.
  • CareSimple, Inc.
  • Veta Health LLC
  • Others

Recent mHealth Industry News, Research and Technology Developments

mHealth App Privacy Under Scrutiny as Study Reveals Data Protection Gaps

Published: October 22, 2025

Researchers from the University of Bremen examined 20 popular mHealth applications available in Germany and identified important gaps between stated privacy practices and actual app behaviour. Several applications reportedly transmitted personal information, including advertising identifiers, before users had provided consent. The research also identified international data transfers, unclear privacy disclosures and manipulative consent-interface designs known as dark patterns.

These findings are highly relevant to the Global mHealth Market because privacy, informed consent and secure health-data management directly affect consumer trust and application adoption. mHealth developers may increasingly need to adopt privacy-by-design practices, transparent consent procedures, multilingual privacy policies and clearer disclosure of third-party data recipients.

Source: Tech Xplore – University of Bremen Study

Real-World Data Emerges as a Key Tool for Evaluating mHealth Application Effectiveness

Published: April 8, 2026

A scoping review published in npj Digital Medicine evaluated 72 studies covering 61 patient-facing mHealth applications. The research examined how real-world data generated during routine app use is being applied to measure the effectiveness of mobile health solutions. User-entered information was the most frequently used data source, while device-generated data and healthcare-system data were used less frequently.

The study highlights an important development in the Global mHealth Market: healthcare providers, regulators, payers and investors are increasingly looking for evidence of real-world clinical performance rather than relying only on controlled trials or application-download figures. Stronger integration of wearable-device data, electronic health records, claims data and long-term patient outcomes could support regulatory approval, reimbursement decisions and post-market monitoring.

Source: npj Digital Medicine – Nature Portfolio

Culturally Adapted Mental mHealth Apps Could Expand Access and Improve User Engagement

Published: May 4, 2026

Research published in Frontiers in Digital Health introduced a framework for developing culturally responsive mental mHealth applications. The framework covers four interconnected areas: adaptation of the therapeutic foundation, culturally relevant features and tools, customized content and messaging, and culturally appropriate user-experience and interface design.

The research indicates that simple language translation may not be sufficient for expanding mental mHealth applications across different populations. Developers may need to consider cultural beliefs, religious factors, communication preferences, family involvement, visual design and community-led co-design. This creates new market opportunities for localized mHealth platforms designed for specific countries, languages and cultural groups.

Source: Frontiers in Digital Health

AI and Machine Learning Are Reshaping the Future of Mobile Healthcare

Published: June 28, 2026
Updated: July 26, 2026

Artificial intelligence and machine learning are becoming increasingly important across the mHealth ecosystem. Their applications include symptom assessment, clinical-data analysis, personalized treatment support, prescription review, patient prioritization, behavioural coaching and automated customer assistance. AI-enabled mobile platforms can also process data collected through smartphones, connected medical devices and wearable health technologies.

The integration of AI, machine learning, Internet of Things devices, electronic health records and mobile applications is supporting the transition toward more connected and proactive healthcare. For the Global mHealth Market, these technologies can improve remote monitoring, clinical workflow efficiency, patient engagement and personalized care. However, successful commercialization will also depend on data security, clinical accuracy, regulatory compliance and integration with existing healthcare systems.

Source: QUASA – The Rise of Health Mobile Apps and mHealth Applications of AI and ML

Key mHealth Industry Insights, Research and Market Developments

Healthcare Software Ecosystem Expands Around Mobile, Remote and Interoperable Care

Updated: July 21, 2026

The healthcare software ecosystem is expanding across clinical records, care delivery, administrative systems, diagnostics and patient-facing mobile solutions. mHealth applications and consumer health-tracking platforms form an important part of the patient-facing and mobile healthcare segment, while telemedicine and remote patient monitoring platforms support digital care delivery.

The development highlights the growing importance of interoperability between mHealth applications, electronic health records, connected medical devices and clinical platforms. Compliance with healthcare data-protection requirements and support for standards such as HL7 FHIR are becoming important considerations for mHealth developers, healthcare providers and technology buyers.

Source: Netguru – 16 Types of Healthcare Software in 2026

Telehealth and mHealth Governance Moves Beyond Access to Privacy, Equity and Regulation

Published: November 13, 2023

The National Academy of Medicine examined telehealth and mobile health as rapidly evolving healthcare technologies requiring coordinated governance across healthcare, government, academia, private companies and consumer groups. Modern mHealth includes mobile applications, wearable devices, ambient sensors, social-media tools and location-based technologies used to support health and wellness.

The study highlights several factors influencing the Global mHealth Market, including regulation, reimbursement, affordability, patient access, data privacy and digital equity. While mHealth can expand access to healthcare and support the management of chronic conditions, its long-term adoption depends on clear regulatory definitions, secure data handling and equitable access to mobile technologies.

Source: National Academy of Medicine – Telehealth and Mobile Health Case Study

Mental Health Apps Expand Consumer Access to Therapy, Sleep and Stress-Management Support

Updated: September 22, 2025

Consumer-facing mental health applications are becoming an important part of the mHealth ecosystem. Popular platforms provide access to online therapy, therapist messaging, meditation, sleep support, breathwork, mood tracking, guided journaling and cognitive behavioural therapy exercises.

The reviewed applications include Talkspace, BetterHelp, Headspace, Calm, Breathwrk and Worry Watch. Their services demonstrate the variety of subscription-based and freemium business models operating in the mental mHealth segment. The development also highlights the importance of reviewing privacy policies, health-data protections, third-party data sharing and insurance coverage before selecting a mental health application.

Source: Verywell Mind – The Best Mental Health Apps, According to a Therapist

Germany’s DiGA Model Highlights the Cost-Effectiveness Challenge for Reimbursed mHealth Apps

Published: November 17, 2024

A study published in npj Digital Medicine evaluated the cost-effectiveness of reimbursable digital health applications, known as DiGA, for depression in Germany. The analysis compared the existing standard of care with a future scenario in which 50% of eligible patients received supplementary access to a DiGA.

The model estimated an additional gain of approximately 0.02 quality-adjusted life years per patient, together with approximately EUR 1,536 in additional direct costs per patient over five years. Under Germany’s existing cost structure, the evaluated depression applications did not demonstrate overall healthcare cost savings.

The findings are relevant to the mHealth market because they show that clinical effectiveness alone may not guarantee reimbursement success. Application pricing, demonstrated patient outcomes, healthcare savings and long-term economic evidence are increasingly important for market access and payer adoption.

Source: npj Digital Medicine – Cost-Effectiveness of mHealth Applications for Depression

Scaling mHealth Programs in India Requires Lifecycle Costing and Sustainable Funding

Published: June 2, 2022

Research published in Frontiers in Public Health examined the financial planning required to implement a large-scale mHealth intervention in India. The study focused on the Integrated Child Development Services–Common Application Software, a mobile job-aid and behaviour-change communication platform used by frontline community workers.

The researchers applied the Activity-Based Costing–Ingredients method to identify the activities, resources and costs associated with implementing and scaling the program. The study emphasized that mHealth budgets should include technology procurement, staff training, maintenance, device replacement, monitoring, indirect expenses and long-term operating costs.

The findings indicate that sustainable mHealth expansion requires detailed cost data, technology-lifecycle planning, identification of all funding sources and scenario-based budgeting. These factors are particularly important for governments and healthcare organizations planning large mHealth deployments in low- and middle-income countries.

Source: Frontiers in Public Health – Costing a Large mHealth Intervention at Scale in India

Table of Contents

Section Title Page
1. GLOBAL MHEALTH MARKET–REPORT OVERVIEW 20
1.1. SCOPE OF THE REPORT 21
1.2. MARKET SEGMENT ANALYSIS 22
1.3. REGULATORY SCENARIO BY REGION/COUNTRY 25
1.4. MARKET INVESTMENT SCENARIO STRATEGIC 25
1.5. MARKET ANALYSIS BY OFFERING (USD MILLION) 26
1.5.1 GLOBAL MHEALTH MARKET SHARE BY OFFERING (2024-2040) 26
1.5.2 MHEALTH APPLICATIONS AND SOFTWARE 26
1.5.2.1 Standalone mHealth Applications 26
1.5.2.2 Connected-Device Companion Applications 26
1.5.2.3 Clinical Mobile Software 26
1.5.2.4 Enterprise mHealth Platforms 26
1.5.2.5 mHealth Data Integration and Analytics Software 26
1.5.3 CONNECTED MHEALTH DEVICES 26
1.5.3.1 Wearable mHealth Devices 26
1.5.3.2 Handheld and Portable Monitoring Devices 26
1.5.3.3 Smartphone-Connected Diagnostic Accessories 26
1.5.3.4 Connected Home Health Monitoring Devices 26
1.5.3.5 Connected Medication Delivery and Adherence Devices 26
1.5.3.6 Connected Implantable Monitoring and Therapeutic Devices 26
1.5.4 MHEALTH SERVICES 26
1.5.4.1 Remote Patient Monitoring Services 26
1.5.4.2 Mobile Teleconsultation Services 26
1.5.4.3 Mobile Diagnostic and Screening Services 26
1.5.4.4 Mobile Treatment and Therapy Support Services 26
1.5.4.5 Mobile Rehabilitation Services 26
1.5.4.6 Mobile Health Information and Education Services 26
1.5.4.7 Mobile Care Coordination Services 26
1.5.4.8 Mobile Emergency Response Services 26
1.6. GLOBAL MHEALTH MARKET SHARE BY OFFERING IN 2024 & 2040 27
1.7. MARKET ANALYSIS BY MHEALTH APPLICATION TYPE (USD MILLION) 28
1.7.1 GLOBAL MHEALTH MARKET SHARE BY MHEALTH APPLICATION TYPE (2024-2040) 28
1.7.2 MEDICAL AND CLINICAL APPLICATIONS 29
1.7.2.1 Chronic Disease Management Applications 29
1.7.2.1.1 Diabetes Management Applications 29
1.7.2.1.2 Cardiovascular Disease Management Applications 29
1.7.2.1.3 Respiratory Disease Management Applications 29
1.7.2.1.4 Neurological Disease Management Applications 29
1.7.2.1.5 Cancer Management Applications 29
1.7.2.1.6 Renal Disease Management Applications 29
1.7.2.1.7 Musculoskeletal and Chronic Pain Management Applications 29
1.7.2.1.8 Other Chronic Disease Management Applications 29
1.7.2.2 Medication Management and Adherence Applications 29
1.7.2.3 Symptom Assessment and Patient-Triage Applications 29
1.7.2.4 Diagnostic and Screening Applications 29
1.7.2.5 Clinical Decision-Support Applications 29
1.7.2.6 Medical Reference and Professional Education Applications 29
1.7.2.7 Electronic Prescription Applications 29
1.7.2.8 Patient Portal and Personal Health Record Applications 29
1.7.2.9 Mental and Behavioral Health Applications 29
1.7.2.10 Women’s, Reproductive and Maternal Health Applications 29
1.7.2.11 Rehabilitation and Physiotherapy Applications 29
1.7.2.12 Digital Therapeutics Applications 29
1.7.2.13 Emergency Care and First-Aid Applications 29
1.7.2.14 Clinical Communication and Care-Team Collaboration Applications 29
1.7.3 WELLNESS AND PREVENTIVE HEALTH APPLICATIONS 29
1.7.3.1 Fitness and Physical Activity Applications 29
1.7.3.2 Nutrition and Diet Management Applications 29
1.7.3.3 Weight Management Applications 29
1.7.3.4 Sleep and Recovery Applications 29
1.7.3.5 Stress Management and Mindfulness Applications 29
1.7.3.6 Smoking and Substance-Cessation Applications 29
1.7.3.7 Preventive Health and Lifestyle-Coaching Applications 29
1.7.3.8 Healthy Ageing Applications 29
1.8. GLOBAL MHEALTH MARKET SHARE BY MHEALTH APPLICATION TYPE IN 2024 & 2040 30
1.9. MARKET ANALYSIS BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 31
1.9.1 GLOBAL MHEALTH MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2024-2040) 31
1.9.2 WEARABLE DEVICES 32
1.9.2.1 Smartwatches and Fitness Bands 32
1.9.2.2 Wearable Medical Patches 32
1.9.2.3 Smart Clothing and Electronic Textiles 32
1.9.2.4 Head-Worn and Ear-Worn Devices 32
1.9.2.5 Wearable Rings 32
1.9.2.6 Other Wearable Devices 32
1.9.3 HANDHELD AND PORTABLE DEVICES 32
1.9.3.1 Handheld Vital-Sign Monitors 32
1.9.3.2 Portable Cardiac Monitoring Devices 32
1.9.3.3 Portable Respiratory Monitoring Devices 32
1.9.3.4 Portable Metabolic Monitoring Devices 32
1.9.3.5 Other Handheld and Portable Devices 32
1.9.4 SMARTPHONE- AND TABLET-CONNECTED ACCESSORIES 32
1.9.4.1 Smartphone-Connected ECG Devices 32
1.9.4.2 Smartphone-Connected Blood Pressure Monitors 32
1.9.4.3 Smartphone-Connected Glucose Monitoring Devices 32
1.9.4.4 Smartphone-Connected Pulse Oximeters 32
1.9.4.5 Smartphone-Connected Otoscopes 32
1.9.4.6 Smartphone-Connected Dermatoscopes 32
1.9.4.7 Smartphone-Connected Ultrasound Devices 32
1.9.4.8 Smartphone-Connected Laboratory and Diagnostic Readers 32
1.9.4.9 Other Smartphone-Connected Accessories 32
1.9.5 CONNECTED HOME HEALTH DEVICES 32
1.9.5.1 Connected Blood Pressure Monitors 32
1.9.5.2 Connected Blood Glucose Monitors 32
1.9.5.3 Connected Pulse Oximeters 32
1.9.5.4 Connected Weighing Scales 32
1.9.5.5 Connected Thermometers 32
1.9.5.6 Connected Respiratory Devices 32
1.9.5.7 Connected Multi-Parameter Monitors 32
1.9.5.8 Other Connected Home Health Devices 32
1.9.6 CONNECTED MEDICATION MANAGEMENT DEVICES 32
1.9.6.1 Connected Inhalers 32
1.9.6.2 Connected Insulin Pens 32
1.9.6.3 Connected Insulin Pumps 32
1.9.6.4 Connected Injection Devices 32
1.9.6.5 Smart Pill Dispensers 32
1.9.6.6 Smart Medication Packaging 32
1.9.6.7 Other Connected Medication Devices 33
1.9.7 CONNECTED IMPLANTABLE DEVICES 33
1.9.7.1 Connected Cardiac Implantable Devices 33
1.9.7.2 Connected Implantable Glucose Sensors 33
1.9.7.3 Connected Neurostimulation Devices 33
1.9.7.4 Other Connected Implantable Devices 33
1.10. GLOBAL MHEALTH MARKET SHARE BY CONNECTED DEVICE FORM FACTOR IN 2024 & 2040 34
1.11. MARKET ANALYSIS BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 35
1.11.1 GLOBAL MHEALTH MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2024-2040) 35
1.11.2 SINGLE-PARAMETER MONITORING 35
1.11.2.1 Cardiac Rhythm and ECG Monitoring 35
1.11.2.2 Heart-Rate Monitoring 35
1.11.2.3 Blood Pressure Monitoring 35
1.11.2.4 Blood Glucose Monitoring 35
1.11.2.5 Blood-Oxygen Saturation Monitoring 35
1.11.2.6 Respiratory Rate and Lung-Function Monitoring 35
1.11.2.7 Body-Temperature Monitoring 35
1.11.2.8 Sleep Monitoring 35
1.11.2.9 Neurological and Brain-Activity Monitoring 35
1.11.2.10 Physical Activity and Energy-Expenditure Monitoring 35
1.11.2.11 Weight and Body-Composition Monitoring 35
1.11.2.12 Maternal and Fetal Monitoring 35
1.11.2.13 Medication-Usage Monitoring 35
1.11.2.14 Other Single-Parameter Monitoring 35
1.11.3 MULTI-PARAMETER MONITORING 35
1.11.3.1 Consumer Multi-Parameter Monitoring 35
1.11.3.2 Clinical Multi-Parameter Monitoring 35
1.12. GLOBAL MHEALTH MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION IN 2024 & 2040 36
1.13. MARKET ANALYSIS BY PRIMARY CLINICAL USE CASE (USD MILLION) 37
1.13.1 GLOBAL MHEALTH MARKET SHARE BY PRIMARY CLINICAL USE CASE (2024-2040) 37
1.13.2 HEALTH PROMOTION AND DISEASE PREVENTION 38
1.13.3 RISK ASSESSMENT AND EARLY SCREENING 38
1.13.4 DIAGNOSIS AND CLINICAL DECISION SUPPORT 38
1.13.5 CONTINUOUS AND INTERMITTENT PATIENT MONITORING 38
1.13.6 TREATMENT AND THERAPEUTIC INTERVENTION 38
1.13.7 MEDICATION MANAGEMENT AND ADHERENCE 38
1.13.8 REHABILITATION AND RECOVERY MANAGEMENT 38
1.13.9 POST-TREATMENT FOLLOW-UP 38
1.13.10 PATIENT EDUCATION AND SELF-MANAGEMENT 38
1.13.11 CLINICAL COMMUNICATION AND CARE COORDINATION 38
1.13.12 EMERGENCY DETECTION AND RESPONSE 38
1.13.13 PUBLIC-HEALTH SURVEILLANCE AND POPULATION MANAGEMENT 38
1.14. GLOBAL MHEALTH MARKET SHARE BY PRIMARY CLINICAL USE CASE IN 2024 & 2040 39
1.15. MARKET ANALYSIS BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 40
1.15.1 GLOBAL MHEALTH MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2024-2040) 40
1.15.2 CARDIOVASCULAR DISEASES 41
1.15.2.1 Hypertension 41
1.15.2.2 Arrhythmia 41
1.15.2.3 Heart Failure 41
1.15.2.4 Coronary Artery Disease 41
1.15.2.5 Other Cardiovascular Diseases 41
1.15.3 DIABETES AND METABOLIC DISORDERS 41
1.15.3.1 Type 1 Diabetes 41
1.15.3.2 Type 2 Diabetes 41
1.15.3.3 Obesity and Weight-Related Disorders 41
1.15.3.4 Other Metabolic Disorders 41
1.15.4 RESPIRATORY DISEASES 41
1.15.4.1 Asthma 41
1.15.4.2 Chronic Obstructive Pulmonary Disease 41
1.15.4.3 Sleep Apnea 41
1.15.4.4 Other Respiratory Diseases 41
1.15.5 MENTAL AND BEHAVIORAL HEALTH DISORDERS 41
1.15.5.1 Anxiety Disorders 41
1.15.5.2 Depression 41
1.15.5.3 Stress-Related Disorders 41
1.15.5.4 Substance-Use Disorders 41
1.15.5.5 Other Mental and Behavioral Disorders 41
1.15.6 NEUROLOGICAL DISORDERS 41
1.15.6.1 Epilepsy 41
1.15.6.2 Parkinson’s Disease 41
1.15.6.3 Alzheimer’s Disease and Dementia 41
1.15.6.4 Migraine and Headache Disorders 41
1.15.6.5 Other Neurological Disorders 41
1.15.7 ONCOLOGY 41
1.15.7.1 Treatment Monitoring 41
1.15.7.2 Symptom and Side-Effect Management 41
1.15.7.3 Survivorship and Follow-Up Care 41
1.15.8 MUSCULOSKELETAL AND PAIN DISORDERS 41
1.15.8.1 Chronic Pain 41
1.15.8.2 Arthritis 41
1.15.8.3 Orthopedic Rehabilitation 41
1.15.8.4 Other Musculoskeletal Disorders 41
1.15.9 WOMEN’S AND REPRODUCTIVE HEALTH 42
1.15.9.1 Menstrual Health 42
1.15.9.2 Fertility and Conception 42
1.15.9.3 Pregnancy and Maternal Health 42
1.15.9.4 Postpartum Health 42
1.15.9.5 Menopause Management 42
1.15.10 RENAL AND UROLOGICAL DISEASES 42
1.15.11 GASTROINTESTINAL DISEASES 42
1.15.12 INFECTIOUS DISEASES 42
1.15.13 DERMATOLOGICAL DISEASES 42
1.15.14 OPHTHALMIC DISORDERS 42
1.15.15 RARE DISEASES 42
1.15.16 OTHER DISEASE AND THERAPEUTIC AREAS 42
1.16. GLOBAL MHEALTH MARKET SHARE BY DISEASE AND THERAPEUTIC AREA IN 2024 & 2040 43
1.17. MARKET ANALYSIS BY PRIMARY USER (USD MILLION) 44
1.17.1 GLOBAL MHEALTH MARKET SHARE BY PRIMARY USER (2024-2040) 44
1.17.2 PATIENTS AND CONSUMERS 45
1.17.3 PHYSICIANS 45
1.17.4 NURSES 45
1.17.5 PHARMACISTS 45
1.17.6 PHYSIOTHERAPISTS AND REHABILITATION PROFESSIONALS 45
1.17.7 BEHAVIORAL AND MENTAL HEALTH PROFESSIONALS 45
1.17.8 DIETITIANS AND NUTRITION PROFESSIONALS 45
1.17.9 CAREGIVERS AND FAMILY MEMBERS 45
1.17.10 COMMUNITY HEALTH WORKERS 45
1.17.11 EMERGENCY MEDICAL PERSONNEL 45
1.17.12 CLINICAL RESEARCHERS 45
1.17.13 HEALTHCARE ADMINISTRATIVE PERSONNEL 45
1.18. GLOBAL MHEALTH MARKET SHARE BY PRIMARY USER IN 2024 & 2040 46
1.19. MARKET ANALYSIS BY CUSTOMER TYPE (USD MILLION) 47
1.19.1 GLOBAL MHEALTH MARKET SHARE BY CUSTOMER TYPE (2024-2040) 47
1.19.2 DIRECT-TO-CONSUMER CUSTOMERS 47
1.19.3 HEALTHCARE PROVIDERS 47
1.19.3.1 Hospitals and Health Systems 47
1.19.3.2 Physician Practices and Clinics 47
1.19.3.3 Diagnostic Centers 47
1.19.3.4 Rehabilitation Centers 47
1.19.3.5 Home Healthcare Providers 47
1.19.3.6 Long-Term Care Providers 47
1.19.4 HEALTH INSURANCE COMPANIES AND PAYERS 47
1.19.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 47
1.19.6 MEDICAL DEVICE COMPANIES 47
1.19.7 EMPLOYERS AND CORPORATE WELLNESS PROVIDERS 47
1.19.8 GOVERNMENT AND PUBLIC-HEALTH ORGANIZATIONS 47
1.19.9 RESEARCH INSTITUTES AND ACADEMIC ORGANIZATIONS 47
1.19.10 NON-GOVERNMENTAL AND HUMANITARIAN ORGANIZATIONS 47
1.20. GLOBAL MHEALTH MARKET SHARE BY CUSTOMER TYPE IN 2024 & 2040 48
1.21. MARKET ANALYSIS BY CARE SETTING (USD MILLION) 49
1.21.1 GLOBAL MHEALTH MARKET SHARE BY CARE SETTING (2024-2040) 49
1.21.2 HOME-BASED CARE 49
1.21.3 HOSPITALS 49
1.21.4 AMBULATORY CLINICS AND PHYSICIAN OFFICES 49
1.21.5 DIAGNOSTIC AND IMAGING CENTERS 49
1.21.6 PHARMACIES AND RETAIL HEALTH SETTINGS 49
1.21.7 REHABILITATION CENTERS 49
1.21.8 LONG-TERM CARE AND ASSISTED-LIVING FACILITIES 49
1.21.9 COMMUNITY AND FIELD-BASED HEALTHCARE 49
1.21.10 WORKPLACE AND CORPORATE HEALTH SETTINGS 49
1.21.11 EMERGENCY AND PREHOSPITAL SETTINGS 49
1.22. GLOBAL MHEALTH MARKET SHARE BY CARE SETTING IN 2024 & 2040 50
1.23. MARKET ANALYSIS BY DEPLOYMENT MODEL (USD MILLION) 51
1.23.1 GLOBAL MHEALTH MARKET SHARE BY DEPLOYMENT MODEL (2024-2040) 51
1.23.2 CLOUD-BASED MHEALTH SOLUTIONS 51
1.23.3 ON-DEVICE AND EDGE-BASED MHEALTH SOLUTIONS 51
1.23.4 ON-PREMISES ENTERPRISE MHEALTH SOLUTIONS 51
1.23.5 HYBRID MHEALTH SOLUTIONS 51
1.24. GLOBAL MHEALTH MARKET SHARE BY DEPLOYMENT MODEL IN 2024 & 2040 52
1.25. MARKET ANALYSIS BY DELIVERY MODEL (USD MILLION) 53
1.25.1 GLOBAL MHEALTH MARKET SHARE BY DELIVERY MODEL (2024-2040) 53
1.25.2 BUSINESS-TO-CONSUMER 53
1.25.3 BUSINESS-TO-BUSINESS 53
1.25.4 BUSINESS-TO-BUSINESS-TO-CONSUMER 53
1.25.5 GOVERNMENT-TO-CITIZEN 53
1.26. GLOBAL MHEALTH MARKET SHARE BY DELIVERY MODEL IN 2024 & 2040 54
1.27. MARKET ANALYSIS BY PRIMARY REVENUE MODEL (USD MILLION) 55
1.27.1 GLOBAL MHEALTH MARKET SHARE BY PRIMARY REVENUE MODEL (2024-2040) 55
1.27.2 SUBSCRIPTION-BASED MODEL 55
1.27.2.1 Monthly Subscription 55
1.27.2.2 Annual Subscription 55
1.27.2.3 Enterprise Subscription 55
1.27.3 ONE-TIME APPLICATION OR SOFTWARE LICENSING 55
1.27.4 PAY-PER-CONSULTATION OR PAY-PER-USE 55
1.27.5 CONNECTED-DEVICE SALES AND BUNDLED SERVICES 55
1.27.6 PROVIDER-, PAYER- OR EMPLOYER-SPONSORED ACCESS 55
1.27.7 ADVERTISING AND LEAD-GENERATION MODEL 55
1.27.8 DATA ANALYTICS AND INSIGHTS LICENSING 55
1.27.9 PUBLIC FUNDING AND GOVERNMENT CONTRACT MODEL 55
1.28. GLOBAL MHEALTH MARKET SHARE BY PRIMARY REVENUE MODEL IN 2024 & 2040 56
1.29. MARKET ANALYSIS BY PRIMARY CONNECTIVITY TECHNOLOGY (USD MILLION) 57
1.29.1 GLOBAL MHEALTH MARKET SHARE BY PRIMARY CONNECTIVITY TECHNOLOGY (2024-2040) 57
1.29.2 BLUETOOTH AND BLUETOOTH LOW ENERGY 57
1.29.3 CELLULAR CONNECTIVITY 57
1.29.3.1 4G/LTE 57
1.29.3.2 5G 57
1.29.3.3 LTE-M 57
1.29.3.4 NB-IoT 57
1.29.4 WI-FI 57
1.29.5 NEAR-FIELD COMMUNICATION 57
1.29.6 LOW-POWER WIDE-AREA NETWORKS 57
1.29.7 SATELLITE CONNECTIVITY 57
1.29.8 MULTI-CONNECTIVITY SOLUTIONS 57
1.30. GLOBAL MHEALTH MARKET SHARE BY PRIMARY CONNECTIVITY TECHNOLOGY IN 2024 & 2040 58
2. DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES IN THE MHEALTH MARKET 59
2.1. DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES ANALYSIS 59
2.1.1 MARKET DRIVER ANALYSIS 59
2.1.1.1 Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxx 59
2.1.2 MARKET RESTRAINT ANALYSIS 59
2.1.2.1 Xxxxxxxxxxxxxxxxxxxx Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 59
2.1.3 MARKET OPPORTUNITY 59
2.1.3.1 Xxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 59
2.1.4 MARKET CHALLENGES 60
2.1.4.1 Xxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxx 60
3. GLOBAL GROWTH TRENDS 61
3.1. INDUSTRY TRENDS 61
3.1.1 SWOT ANALYSIS 61
3.1.1.1 Strengths 61
3.1.1.2 Weaknesses 61
3.1.1.3 Opportunities 61
3.1.1.4 Threats 61
3.1.2 PESTEL ANALYSIS 62
3.1.2.1 Political Landscape 62
3.1.2.2 Economic Landscape 62
3.1.2.3 Social Landscape 63
3.1.2.4 Technological Landscape 63
3.1.2.5 Environmental Landscape 63
3.1.2.6 Legal Landscape 63
3.1.3 PORTER’S FIVE FORCES ANALYSIS 64
3.1.3.1 Bargaining Power of Suppliers 64
3.1.3.2 Bargaining Power of Buyers 65
3.1.3.3 Threat of Substitutesss 65
3.1.3.4 Threat of New Entrantsss 65
3.1.3.5 Competitive Rivalry 65
3.2. POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS 66
4. POST-COVID-19 ANALYSIS 67
4.1. V-SHAPED COVID-19 RECOVERY ANALYSIS 67
4.2. U-SHAPED COVID-19 RECOVERY ANALYSIS 68
4.3. L-SHAPED COVID-19 RECOVERY ANALYSIS 68
4.4. W-SHAPED COVID-19 RECOVERY ANALYSIS 68
5. COMPANIES ANALYSIS 69
5.1. PLAYERS COVERED: RANKING BY MHEALTH REVENUE 70
5.2. MARKET SHARE OF LEADING MHEALTH COMPANIES (%) 70
6. EXECUTIVE SUMMARY 71
7. GLOBAL MHEALTH MARKET FORECAST, 2020-2040 (USD MILLION) 73
7.1. GLOBAL MHEALTH REVENUE AND MARKET SHARE BY REGIONS 73
7.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY REGION (2020-2025) 76
7.3. GLOBAL MHEALTH MARKET AND MARKET SHARE BY REGION (2026-2040) 78
7.3.1.1 North America 81
7.3.1.2 Europe 81
7.3.1.3 Asia Pacific 81
7.3.1.4 Latin America 81
7.3.1.5 Middle East & Africa 81
8. NORTH AMERICA MHEALTH MARKET ANALYSIS BY COUNTRY (USD MILLION) 94
8.1. NORTH AMERICA MHEALTH REVENUE AND MARKET SHARE BY COUNTRY 94
8.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (2020-2025) 95
8.3. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (2026-2040) 97
8.3.1.1 United States 100
8.3.1.2 Canada 100
8.3.1.3 Mexico 100
9. EUROPE MHEALTH MARKET ANALYSIS BY COUNTRY (USD MILLION) 109
9.1. EUROPE MHEALTH REVENUE AND MARKET SHARE BY COUNTRY 109
9.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2020-2025) 110
9.3. EUROPE MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2026-2040) 114
9.3.1.1 United Kingdom 119
9.3.1.2 Germany 119
9.3.1.3 France 119
9.3.1.4 Spain 119
9.3.1.5 Italy 119
9.3.1.6 Rest of Europe 119
10. ASIA PACIFIC MHEALTH MARKET ANALYSIS BY COUNTRY (USD MILLION) (2020-2040) 134
10.1. ASIA PACIFIC MHEALTH REVENUE AND MARKET SHARE BY COUNTRY 134
10.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2020-2025) 135
10.3. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2026-2040) 139
10.3.1.1 China 143
10.3.1.2 India 143
10.3.1.3 Japan 143
10.3.1.4 Australia 143
10.3.1.5 South Korea 143
10.3.1.6 Rest of Asia Pacific 143
11. MIDDLE EAST AND AFRICA MHEALTH MARKET ANALYSIS BY COUNTRY (USD MILLION) 157
11.1. MIDDLE EAST AND AFRICA MHEALTH REVENUE AND MARKET SHARE BY COUNTRY 157
11.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2020-2025) 158
11.3. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2026-2040) 160
11.3.1.1 Saudi Arabia 162
11.3.1.2 South Africa 162
11.3.1.3 Rest of MEA 162
12. LATIN AMERICA MHEALTH MARKET ANALYSIS BY COUNTRY (USD MILLION) 169
12.1. LATIN AMERICA MHEALTH REVENUE AND MARKET SHARE BY COUNTRY 169
12.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2020-2025) 170
12.3. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY COUNTRY (USD MILLION) (2026-2040) 171
12.3.1.1 Brazil 174
12.3.1.2 Argentina 174
12.3.1.3 Rest of Latin America 174
13. GLOBAL MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 182
13.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 182
13.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 183
14. GLOBAL MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 184
14.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 184
14.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 185
15. GLOBAL MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 186
15.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 186
15.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 187
16. GLOBAL MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 189
16.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 189
16.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 190
17. GLOBAL MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 191
17.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 191
17.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 192
18. GLOBAL MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 195
18.1. GLOBAL MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 195
18.2. GLOBAL MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 196
19. NORTH AMERICA MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 199
19.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 199
19.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 200
20. NORTH AMERICA MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 201
20.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 201
20.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 202
21. NORTH AMERICA MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 203
21.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 203
21.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 204
22. NORTH AMERICA MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 206
22.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 206
22.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 207
23. NORTH AMERICA MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 208
23.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 208
23.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 209
24. NORTH AMERICA MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 212
24.1. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 212
24.2. NORTH AMERICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 213
25. EUROPE MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 216
25.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 216
25.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 217
26. EUROPE MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 218
26.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 218
26.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 219
27. EUROPE MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 220
27.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 220
27.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 221
28. EUROPE MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 223
28.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 223
28.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 224
29. EUROPE MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 225
29.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 225
29.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 226
30. EUROPE MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 229
30.1. EUROPE MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 229
30.2. EUROPE MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 230
31. ASIA PACIFIC MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 233
31.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 233
31.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 234
32. ASIA PACIFIC MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 235
32.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 235
32.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 236
33. ASIA PACIFIC MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 237
33.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 237
33.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 238
34. ASIA PACIFIC MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 240
34.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 240
34.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 241
35. ASIA PACIFIC MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 242
35.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 242
35.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 243
36. ASIA PACIFIC MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 246
36.1. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 246
36.2. ASIA PACIFIC MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 247
37. LATIN AMERICA MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 250
37.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 250
37.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 251
38. LATIN AMERICA MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 252
38.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 252
38.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 253
39. LATIN AMERICA MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 254
39.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 254
39.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 255
40. LATIN AMERICA MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 257
40.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 257
40.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 258
41. LATIN AMERICA MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 259
41.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 259
41.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 260
42. LATIN AMERICA MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 263
42.1. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 263
42.2. LATIN AMERICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 264
43. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY OFFERING (USD MILLION) 267
43.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2020-2025) 267
43.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY OFFERING (2026-2040) 268
44. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY MHEALTH APPLICATION TYPE (USD MILLION) 269
44.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2020-2025) 269
44.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY MHEALTH APPLICATION TYPE (2026-2040) 270
45. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY CONNECTED DEVICE FORM FACTOR (USD MILLION) 271
45.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2020-2025) 271
45.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY CONNECTED DEVICE FORM FACTOR (2026-2040) 272
46. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) 274
46.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2020-2025) 274
46.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY MONITORING AND MEASUREMENT FUNCTION (2026-2040) 275
47. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY PRIMARY CLINICAL USE CASE (USD MILLION) 276
47.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2020-2025) 276
47.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY PRIMARY CLINICAL USE CASE (2026-2040) 277
48. MIDDLE EAST & AFRICA MHEALTH MARKET SEGMENT BY DISEASE AND THERAPEUTIC AREA (USD MILLION) 280
48.1. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2020-2025) 280
48.2. MIDDLE EAST & AFRICA MHEALTH MARKET AND MARKET SHARE BY DISEASE AND THERAPEUTIC AREA (2026-2040) 281
49. COMPANY PROFILES (CONNECTED DEVICES, WEARABLES AND MEDICAL MONITORING COMPANIES) 284
49.1. APPLE INC 284
49.1.1 COMPANY DETAILS 284
49.1.2 FINANCIALS (USD MILLIONS) 284
49.1.3 PRODUCT SUMMARY 284
49.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS) 285
49.2. ALPHABET INC. (GOOGLE/FITBIT) 286
49.3. SAMSUNG ELECTRONICS CO., LTD 286
49.4. HUAWEI TECHNOLOGIES CO., LTD 286
49.5. XIAOMI CORPORATION 286
49.6. GARMIN LTD 286
49.7. OURA HEALTH OY 286
49.8. WHOOP, INC 286
49.9. WITHINGS 286
49.10. ZEPP HEALTH CORPORATION 286
49.11. POLAR ELECTRO OY 286
49.12. ABBOTT LABORATORIES 286
49.13. DEXCOM, INC 286
49.14. MEDTRONIC PLC 286
49.15. INSULET CORPORATION 286
49.16. TANDEM DIABETES CARE, INC 286
49.17. SENSEONICS HOLDINGS, INC 286
49.18. F. HOFFMANN-LA ROCHE LTD 286
49.19. YPSOMED HOLDING AG 286
49.20. KONINKLIJKE PHILIPS N.V 286
49.21. GE HEALTHCARE TECHNOLOGIES INC 286
49.22. SIEMENS HEALTHINEERS AG 286
49.23. BOSTON SCIENTIFIC CORPORATION 286
49.24. MASIMO CORPORATION 286
49.25. OMRON HEALTHCARE CO., LTD 286
49.26. IRHYTHM TECHNOLOGIES, INC 286
49.27. RESMED INC 286
49.28. ZOLL MEDICAL CORPORATION 286
49.29. BIOINTELLISENSE, INC 286
49.30. VITALCONNECT, INC 286
49.31. EMPATICA INC 286
49.32. SIBEL HEALTH, INC 286
49.33. ALIVECOR, INC 286
49.34. EKO HEALTH, INC 287
49.35. BUTTERFLY NETWORK, INC 287
49.36. CLARIUS MOBILE HEALTH CORP 287
49.37. TYTOCARE LTD 287
49.38. HEALTHY.IO LTD 287
49.39. BINAH.AI LTD 287
49.40. QOMPIUM NV 287
49.41. AKTIIA SA 287
49.42. BIOBEAT TECHNOLOGIES LTD 287
49.43. CARDIACSENSE LTD 287
49.44. CORSANO HEALTH B.V 287
49.45. SMARTCARDIA SA 287
49.46. LIFESIGNALS, INC 287
49.47. VIVALINK, INC 287
49.48. BIOFOURMIS, INC 287
49.49. HUMA THERAPEUTICS LIMITED 287
49.50. CURRENT HEALTH 287
49.51. OTHERS 287
50. COMPANY PROFILES (TELEHEALTH AND MOBILE VIRTUAL-CARE COMPANIES) 288
50.1. TELADOC HEALTH, INC 288
50.1.1 COMPANY DETAILS 288
50.1.2 FINANCIALS (USD MILLIONS) 288
50.1.3 PRODUCT SUMMARY 288
50.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS) 289
50.2. AMERICAN WELL CORPORATION 289
50.3. INCLUDED HEALTH, INC 289
50.4. DOXIMITY, INC 289
50.5. AMAZON ONE MEDICAL 289
50.6. HIMS & HERS HEALTH, INC 289
50.7. K HEALTH, INC 289
50.8. HEALTHTAP, INC 289
50.9. EVISIT, INC 289
50.10. MDLIVE INC 289
50.11. DOCTOLIB SAS 289
50.12. KRY INTERNATIONAL AB (LIVI) 289
50.13. DOCPLANNER GROUP 289
50.14. PRACTO TECHNOLOGIES PVT. LTD 289
50.15. HALODOC 289
50.16. DOCTOR ANYWHERE PTE. LTD 289
50.17. PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED 289
50.18. JD HEALTH INTERNATIONAL INC 289
50.19. ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED 289
50.20. MAVEN CLINIC CO 289
50.21. OTHERS 289
51. COMPANY PROFILES (CHRONIC DISEASE MANAGEMENT AND DIGITAL THERAPEUTICS COMPANIES) 290
51.1. OMADA HEALTH, INC 290
51.1.1 COMPANY DETAILS 290
51.1.2 FINANCIALS (USD MILLIONS) 290
51.1.3 PRODUCT SUMMARY 290
51.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS) 291
51.2. VIRTA HEALTH CORP 291
51.3. DARIOHEALTH CORP 291
51.4. WELLDOC, INC 291
51.5. LARK TECHNOLOGIES, INC 291
51.6. NOOM, INC 291
51.7. HINGE HEALTH, INC 291
51.8. SWORD HEALTH TECHNOLOGIES, INC 291
51.9. KAIA HEALTH SOFTWARE GMBH 291
51.10. SIDEKICK HEALTH 291
51.11. HELLOBETTER 291
51.12. BIG HEALTH LTD 291
51.13. CLICK THERAPEUTICS, INC 291
51.14. VIRTUAL THERAPEUTICS 291
51.15. WELT CORP 291
51.16. OTHERS 291
52. COMPANY PROFILES (MENTAL AND BEHAVIORAL MHEALTH COMPANIES) 292
52.1. HEADSPACE HEALTH 292
52.1.1 COMPANY DETAILS 292
52.1.2 FINANCIALS (USD MILLIONS) 292
52.1.3 PRODUCT SUMMARY 292
52.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS) 293
52.2. CALM.COM, INC 293
52.3. TALKSPACE, INC 293
52.4. SPRING HEALTH 293
52.5. WYSA LTD 293
52.6. OTHERS 293
53. COMPANY PROFILES (REMOTE PATIENT MONITORING AND CARE-MANAGEMENT COMPANIES) 294
53.1. CADENCE SOLUTIONS 294
53.1.1 COMPANY DETAILS 294
53.1.2 FINANCIALS (USD MILLIONS) 294
53.1.3 PRODUCT SUMMARY 294
53.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS) 295
53.2. HEALTH RECOVERY SOLUTIONS, INC 295
53.3. COACHCARE 295
53.4. VALIDIC, INC 295
53.5. DATOS HEALTH 295
53.6. RIMIDI, INC 295
53.7. LUSCII HEALTHTECH B.V 295
53.8. DOCCLA LTD 295
53.9. CARESIMPLE, INC 295
53.10. VETA HEALTH LLC 295
53.11. OTHERS 295
54. CONCLUSION 296
55. REFERENCE LINK 297
56. APPENDIX 298
56.1. METHODOLOGY 298
56.2. RESEARCH DATA SOURCE 299
56.2.1 SECONDARY DATA 299
56.2.2 KEY DATA FROM SECONDARY 300
56.2.3 PRIMARY DATA 301
56.2.4 KEY DATA FROM PRIMARY 301
56.2.5 INDUSTRY INSIGHTS FROM PROFESSIONAL LEADERS 302
56.2.6 MARKET ESTIMATION 302
56.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACHES 304
56.2.8 LEGAL DISCLAIMER 304
57. RESEARCH SCOPE 305

List of Tables

Table Title Page
Table 1 MARKET SEGMENT 22
Table 2 GLOBAL MHEALTH MARKET GROWTH RATE BY OFFERING (USD MILLION) (2024-2040) 26
Table 3 GLOBAL MHEALTH MARKET GROWTH RATE BY MHEALTH APPLICATION TYPE (USD MILLION) (2024-2040) 28
Table 4 GLOBAL MHEALTH MARKET GROWTH RATE BY CONNECTED DEVICE FORM FACTOR (USD MILLION) (2024-2040) 31
Table 5 GLOBAL MHEALTH MARKET GROWTH RATE BY MONITORING AND MEASUREMENT FUNCTION (USD MILLION) (2024-2040) 35
Table 6 GLOBAL MHEALTH MARKET GROWTH RATE BY PRIMARY CLINICAL USE CASE (USD MILLION) (2024-2040) 37
Table 7 GLOBAL MHEALTH MARKET GROWTH RATE BY DISEASE AND THERAPEUTIC AREA (USD MILLION) (2024-2040) 40
Table 8 GLOBAL MHEALTH MARKET GROWTH RATE BY PRIMARY USER (USD MILLION) (2024-2040) 44
Table 9 GLOBAL MHEALTH MARKET GROWTH RATE BY CUSTOMER TYPE (USD MILLION) (2024-2040) 47
Table 10 GLOBAL MHEALTH MARKET GROWTH RATE BY CARE SETTING (USD MILLION) (2024-2040) 49
Table 11 GLOBAL MHEALTH MARKET GROWTH RATE BY DEPLOYMENT MODEL (USD MILLION) (2024-2040) 51
Table 12 GLOBAL MHEALTH MARKET GROWTH RATE BY DELIVERY MODEL (USD MILLION) (2024-2040) 53
Table 13 GLOBAL MHEALTH MARKET GROWTH RATE BY PRIMARY REVENUE MODEL (USD MILLION) (2024-2040) 55
Table 14 GLOBAL MHEALTH MARKET GROWTH RATE BY PRIMARY CONNECTIVITY TECHNOLOGY (USD MILLION) (2024-2040) 57
Table 15 COMPANY’S RANK BY MHEALTH REVENUE 70
Table 16 GLOBAL MHEALTH MARKET — MARKET SNAPSHOT & KEY BUYING CRITERIA, 2021 – 2040 71
Table 17 GLOBAL MHEALTH MARKET (USD MILLION) (2020-2025) 74
Table 18 GLOBAL MHEALTH MARKET (USD MILLION) (2026-2040) 75
Table 19 GLOBAL MHEALTH MARKET BY REGION, USD MILLION (2020-2025) 76
Table 20 GLOBAL MHEALTH MARKET SHARE BY REGION (2020-2025) 76
Table 21 GLOBAL MHEALTH MARKET BY REGION, USD MILLION (2026-2040) 78
Table 22 GLOBAL MHEALTH MARKET SHARE BY REGION (2026-2040) 79
Table 23 NORTH AMERICA MHEALTH MARKET (USD MILLION) (2020-2025) 81
Table 24 NORTH AMERICA MHEALTH MARKET (USD MILLION) (2026-2040) 83
Table 25 EUROPE MHEALTH MARKET (USD MILLION) (2020-2025) 85
Table 26 EUROPE MHEALTH MARKET (USD MILLION) (2026-2040) 86
Table 27 ASIA PACIFIC MHEALTH MARKET (USD MILLION) (2020-2025) 87
Table 28 ASIA PACIFIC MHEALTH MARKET (USD MILLION) (2026-2040) 88
Table 29 MIDDLE EAST AND AFRICA MHEALTH MARKET (USD MILLION) (2020-2025) 89
Table 30 MIDDLE EAST AND AFRICA MHEALTH MARKET (USD MILLION) (2026-2040) 90
Table 31 LATIN AMERICA MHEALTH MARKET (USD MILLION) (2020-2025) 91
Table 32 LATIN AMERICA MHEALTH MARKET (USD MILLION) (2026-2040) 92
Table 33 NORTH AMERICA MHEALTH MARKET BY COUNTRY (2020-2025) 95
Table 34 NORTH AMERICA MHEALTH MARKET SHARE BY COUNTRY (2020-2025) 96
Table 35 NORTH AMERICA MHEALTH MARKET BY COUNTRY (2026-2040) 97
Table 36 NORTH AMERICA MHEALTH MARKET SHARE BY COUNTRY (2026-2040) 99
Table 37 UNITED STATES MHEALTH MARKET (USD MILLION) (2020-2025) 100
Table 38 UNITED STATES MHEALTH MARKET (USD MILLION) (2026-2040) 102
Table 39 CANADA MHEALTH MARKET (USD MILLION) (2020-2025) 104
Table 40 CANADA MHEALTH MARKET (USD MILLION) (2026-2040) 105
Table 41 MEXICO MHEALTH MARKET (USD MILLION) (2020-2025) 106
Table 42 MEXICO MHEALTH MARKET (USD MILLION) (2026-2040) 107
Table 43 EUROPE MHEALTH MARKET BY COUNTRY (USD MILLION) (2020-2025) 110
Table 44 EUROPE MHEALTH MARKET SHARE BY COUNTRY (USD MILLION) (2020-2025) 112
Table 45 EUROPE MHEALTH MARKET BY COUNTRY (USD MILLION) (2026-2040) 114
Table 46 EUROPE MHEALTH MARKET SHARE BY COUNTRY (USD MILLION) (2026-2040) 117
Table 47 UNITED KINGDOM MHEALTH MARKET (USD MILLION) (2020-2025) 120
Table 48 UNITED KINGDOM MHEALTH MARKET (USD MILLION) (2026-2040) 121
Table 49 GERMANY MHEALTH MARKET (USD MILLION) (2020-2025) 123
Table 50 GERMANY MHEALTH MARKET (USD MILLION) (2026-2040) 124
Table 51 FRANCE MHEALTH MARKET (USD MILLION) (2020-2025) 125
Table 52 FRANCE MHEALTH MARKET (USD MILLION) (2026-2040) 126
Table 53 SPAIN MHEALTH MARKET (USD MILLION) (2020-2025) 127
Table 54 SPAIN MHEALTH MARKET (USD MILLION) (2026-2040) 128
Table 55 ITALY MHEALTH MARKET (USD MILLION) (2020-2025) 129
Table 56 ITALY MHEALTH MARKET (USD MILLION) (2026-2040) 130
Table 57 REST OF EUROPE MHEALTH MARKET (USD MILLION) (2020-2025) 131
Table 58 REST OF EUROPE MHEALTH MARKET (USD MILLION) (2026-2040) 132
Table 59 ASIA PACIFIC MHEALTH MARKET BY COUNTRY (USD MILLION) (2020-2025) 135
Table 60 ASIA PACIFIC MHEALTH MARKET SHARE BY COUNTRY, (%) (2020-2025) 137
Table 61 ASIA PACIFIC MHEALTH MARKET BY COUNTRY (2026-2040) 139
Table 62 ASIA PACIFIC MHEALTH MARKET SHARE BY COUNTRY, (%) (2026-2040) 141
Table 63 CHINA MHEALTH MARKET (USD MILLION) (2020-2025) 144
Table 64 CHINA MHEALTH MARKET (USD MILLION) (2026-2040) 145
Table 65 INDIA MHEALTH MARKET (USD MILLION) (2020-2025) 146
Table 66 INDIA MHEALTH MARKET (USD MILLION) (2026-2040) 147
Table 67 JAPAN MHEALTH MARKET (USD MILLION) (2020-2025) 148
Table 68 JAPAN MHEALTH MARKET (USD MILLION) (2026-2040) 149
Table 69 AUSTRALIA MHEALTH MARKET (USD MILLION) (2020-2025) 150
Table 70 AUSTRALIA MHEALTH MARKET (USD MILLION) (2026-2040) 151
Table 71 SOUTH KOREA MHEALTH MARKET (USD MILLION) (2020-2025) 152
Table 72 SOUTH KOREA MHEALTH MARKET (USD MILLION) (2026-2040) 153
Table 73 REST OF ASIA PACIFIC MHEALTH MARKET (USD MILLION) (2020-2025) 154
Table 74 REST OF ASIA PACIFIC MHEALTH MARKET (USD MILLION) (2026-2040) 155
Table 75 MIDDLE EAST & AFRICA MHEALTH MARKET BY COUNTRY (USD MILLION) (2020-2025) 158
Table 76 MIDDLE EAST & AFRICA MHEALTH MARKET SHARE BY COUNTRY (2020-2025) 158
Table 77 MIDDLE EAST & AFRICA MHEALTH MARKET BY COUNTRY (2026-2040) 160
Table 78 MIDDLE EAST & AFRICA MHEALTH MARKET SHARE BY COUNTRY (2026-2040) 161
Table 79 SAUDI ARABIA MHEALTH MARKET (USD MILLION) (2020-2025) 162
Table 80 SAUDI ARABIA MHEALTH MARKET (USD MILLION) (2026-2040) 164
Table 81 SOUTH AFRICA MHEALTH MARKET (USD MILLION) (2020-2025) 165
Table 82 SOUTH AFRICA MHEALTH MARKET (USD MILLION) (2026-2040) 166
Table 83 REST OF MEA MHEALTH MARKET (USD MILLION) (2020-2025) 167
Table 84 REST OF MEA MHEALTH MARKET (USD MILLION) (2026-2040) 168
Table 85 LATIN AMERICA MHEALTH MARKET BY COUNTRY (USD MILLION) (2020-2025) 170
Table 86 LATIN AMERICA MHEALTH MARKET SHARE BY COUNTRY, (%) (2020-2025) 170
Table 87 LATIN AMERICA MHEALTH MARKET BY COUNTRY (2026-2040) 171
Table 88 LATIN AMERICA MHEALTH MARKET SHARE BY COUNTRY, (%) (2026-2040) 173
Table 89 BRAZIL MHEALTH MARKET (USD MILLION) (2020-2025) 174
Table 90 BRAZIL MHEALTH MARKET (USD MILLION) (2026-2040) 176
Table 91 ARGENTINA MHEALTH MARKET (USD MILLION) (2020-2025) 177
Table 92 ARGENTINA MHEALTH MARKET (USD MILLION) (2026-2040) 178
Table 93 REST OF LATIN AMERICA MHEALTH MARKET (USD MILLION) (2020-2025) 179
Table 94 REST OF LATIN AMERICA MHEALTH MARKET (USD MILLION) (2026-2040) 180
Table 95 GLOBAL MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 182
Table 96 GLOBAL MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 183
Table 97 GLOBAL MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025) 184
Table 98 GLOBAL MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040) 185
Table 99 GLOBAL MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 186
Table 100 GLOBAL MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 187
Table 101 GLOBAL MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 189
Table 102 GLOBAL MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 190
Table 103 GLOBAL MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025) 191
Table 104 GLOBAL MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040) 192
Table 105 GLOBAL MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025). 195
Table 106 GLOBAL MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040). 196
Table 107 NORTH AMERICA MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 199
Table 108 NORTH AMERICA MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 200
Table 109 NORTH AMERICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025) 201
Table 110 NORTH AMERICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040) 202
Table 111 NORTH AMERICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 203
Table 112 NORTH AMERICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 204
Table 113 NORTH AMERICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 206
Table 114 NORTH AMERICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 207
Table 115 NORTH AMERICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025) 208
Table 116 NORTH AMERICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040) 209
Table 117 NORTH AMERICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025) 212
Table 118 NORTH AMERICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040) 213
Table 119 EUROPE MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 216
Table 120 EUROPE MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 217
Table 121 EUROPE MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025) 218
Table 122 EUROPE MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040) 219
Table 123 EUROPE MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 220
Table 124 EUROPE MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 221
Table 125 EUROPE MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 223
Table 126 EUROPE MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 224
Table 127 EUROPE MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025) 225
Table 128 EUROPE MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040) 226
Table 129 EUROPE MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025) 229
Table 130 EUROPE MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040) 230
Table 131 ASIA PACIFIC MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 233
Table 132 ASIA PACIFIC MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 234
Table 133 ASIA PACIFIC MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025). 235
Table 134 ASIA PACIFIC MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040). 236
Table 135 ASIA PACIFIC MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 237
Table 136 ASIA PACIFIC MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 238
Table 137 ASIA PACIFIC MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 240
Table 138 ASIA PACIFIC MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 241
Table 139 ASIA PACIFIC MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025). 242
Table 140 ASIA PACIFIC MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040). 243
Table 141 ASIA PACIFIC MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025) 246
Table 142 ASIA PACIFIC MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040) 247
Table 143 LATIN AMERICA MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 250
Table 144 LATIN AMERICA MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 251
Table 145 LATIN AMERICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025) 252
Table 146 LATIN AMERICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040) 253
Table 147 LATIN AMERICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 254
Table 148 LATIN AMERICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 255
Table 149 LATIN AMERICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 257
Table 150 LATIN AMERICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 258
Table 151 LATIN AMERICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025) 259
Table 152 LATIN AMERICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040) 260
Table 153 LATIN AMERICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025) 263
Table 154 LATIN AMERICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040) 264
Table 155 MIDDLE EAST & AFRICA MHEALTH MARKET BY OFFERING, USD MILLION (2020-2025) 267
Table 156 MIDDLE EAST & AFRICA MHEALTH MARKET BY OFFERING, USD MILLION (2026-2040) 268
Table 157 MIDDLE EAST & AFRICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2020-2025) 269
Table 158 MIDDLE EAST & AFRICA MHEALTH MARKET BY MHEALTH APPLICATION TYPE, USD MILLION (2026-2040) 270
Table 159 MIDDLE EAST & AFRICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2020-2025) 271
Table 160 MIDDLE EAST & AFRICA MHEALTH MARKET BY CONNECTED DEVICE FORM FACTOR, USD MILLION (2026-2040) 272
Table 161 MIDDLE EAST & AFRICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2020-2025) 274
Table 162 MIDDLE EAST & AFRICA MHEALTH MARKET BY MONITORING AND MEASUREMENT FUNCTION, USD MILLION (2026-2040) 275
Table 163 MIDDLE EAST & AFRICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2020-2025) 276
Table 164 MIDDLE EAST & AFRICA MHEALTH MARKET BY PRIMARY CLINICAL USE CASE, USD MILLION (2026-2040) 277
Table 165 MIDDLE EAST & AFRICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2020-2025) 280
Table 166 MIDDLE EAST & AFRICA MHEALTH MARKET BY DISEASE AND THERAPEUTIC AREA, USD MILLION (2026-2040) 281

List of Figures

Figure Title Page
Figure 1 MARKET OVERVIEW 20
Figure 2 REGIONAL SHARE 25
Figure 3 MARKET REVENUE (USD MILLION) 25
Figure 4 MHEALTH DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (DROC) ANALYSIS 59
Figure 5 SWOT ANALYSIS 61
Figure 6 PESTEL ANALYSIS 62
Figure 7 PORTER’S FIVE FORCES ANALYSIS 64
Figure 8 COVID-19 RECOVERY SCENARIO ANALYSIS 67
Figure 9 LEADING COMPANIES 69
Figure 10 REGIONAL ANALYSIS 73
Figure 11 COUNTRY ANALYSIS 73
Figure 12 GLOBAL MHEALTH MARKET (2020-2025) (USD MILLION) 74
Figure 13 GLOBAL MHEALTH MARKET (2026-2040) (USD MILLION) 75
Figure 14 GLOBAL MHEALTH MARKET (2020-2025) (USD MILLION), BY REGION 76
Figure 15 GLOBAL MHEALTH MARKET SHARE (2022), BY REGION 77
Figure 16 GLOBAL MHEALTH MARKET (2026-2040) (USD MILLION), BY REGION 79
Figure 17 GLOBAL MHEALTH MARKET SHARE (2040), BY REGION 81
Figure 18 NORTH AMERICA MHEALTH MARKET (2020-2025) (USD MILLION) 82
Figure 19 NORTH AMERICA MHEALTH MARKET (2026-2040) (USD MILLION) 83
Figure 20 EUROPE MHEALTH MARKET (2020-2025) (USD MILLION) 85
Figure 21 EUROPE MHEALTH MARKET (2026-2040) (USD MILLION) 86
Figure 22 ASIA PACIFIC MHEALTH MARKET (2020-2025) (USD MILLION) 87
Figure 23 ASIA PACIFIC MHEALTH MARKET (2026-2040) (USD MILLION) 88
Figure 24 MIDDLE EAST AND AFRICA MHEALTH MARKET (2020-2025) (USD MILLION) 89
Figure 25 MIDDLE EAST AND AFRICA MHEALTH MARKET (2026-2040) (USD MILLION) 90
Figure 26 LATIN AMERICA MHEALTH MARKET (2020-2025) (USD MILLION) 91
Figure 27 LATIN AMERICA MHEALTH MARKET (2026-2040) (USD MILLION) 92
Figure 28 NORTH AMERICA MHEALTH MARKET (2020-2025) (USD MILLION), BY COUNTRY 95
Figure 29 NORTH AMERICA MHEALTH MARKET SHARE (2023), BY COUNTRY 96
Figure 30 NORTH AMERICA MHEALTH MARKET (2026-2040) (USD MILLION), BY COUNTRY 98
Figure 31 NORTH AMERICA MHEALTH MARKET SHARE (2040), BY COUNTRY 100
Figure 32 UNITED STATES MHEALTH MARKET (2020-2025) (USD MILLION) 101
Figure 33 UNITED STATES MHEALTH MARKET (2026-2040) (USD MILLION) 102
Figure 34 CANADA MHEALTH MARKET (2020-2025) (USD MILLION) 104
Figure 35 CANADA MHEALTH MARKET (2026-2040) (USD MILLION) 105
Figure 36 MEXICO MHEALTH MARKET (2020-2025) (USD MILLION) 106
Figure 37 MEXICO MHEALTH MARKET (2026-2040) (USD MILLION) 107
Figure 38 EUROPE MHEALTH MARKET (2020-2025) (USD MILLION), BY COUNTRY 111
Figure 39 EUROPE MHEALTH MARKET SHARE (2023), BY COUNTRY 113
Figure 40 EUROPE MHEALTH MARKET (2026-2040) (USD MILLION), BY COUNTRY 116
Figure 41 EUROPE MHEALTH MARKET SHARE (2030), BY COUNTRY 119
Figure 42 UNITED KINGDOM MHEALTH MARKET (2020-2025) (USD MILLION) 120
Figure 43 UNITED KINGDOM MHEALTH MARKET (2026-2040) (USD MILLION) 121
Figure 44 GERMANY MHEALTH MARKET (2020-2025) (USD MILLION) 123
Figure 45 GERMANY MHEALTH MARKET (2026-2040) (USD MILLION) 124
Figure 46 FRANCE MHEALTH MARKET (2020-2025) (USD MILLION) 125
Figure 47 FRANCE MHEALTH MARKET (2026-2040) (USD MILLION) 126
Figure 48 SPAIN MHEALTH MARKET (2020-2025) (USD MILLION) 127
Figure 49 SPAIN MHEALTH MARKET (2026-2040) (USD MILLION) 128
Figure 50 ITALY MHEALTH MARKET (2020-2025) (USD MILLION) 129
Figure 51 ITALY MHEALTH MARKET (2026-2040) (USD MILLION) 130
Figure 52 REST OF EUROPE MHEALTH MARKET (2020-2025) (USD MILLION) 131
Figure 53 REST OF EUROPE MHEALTH MARKET (2026-2040) (USD MILLION) 132
Figure 54 ASIA PACIFIC MHEALTH MARKET (2020-2025) (USD MILLION), BY COUNTRY 136
Figure 55 ASIA PACIFIC MHEALTH MARKET SHARE (2023), BY COUNTRY 138
Figure 56 ASIA PACIFIC MHEALTH MARKET (2024-2040) (USD MILLION), BY COUNTRY 140
Figure 57 ASIA PACIFIC MHEALTH MARKET SHARE (2040), BY COUNTRY 143
Figure 58 CHINA MHEALTH MARKET (2020-2025) (USD MILLION) 144
Figure 59 CHINA MHEALTH MARKET (2026-2040) (USD MILLION) 145
Figure 60 INDIA MHEALTH MARKET (2020-2025) (USD MILLION) 146
Figure 61 INDIA MHEALTH MARKET (2026-2040) (USD MILLION) 147
Figure 62 JAPAN MHEALTH MARKET (2020-2025) (USD MILLION) 148
Figure 63 JAPAN MHEALTH MARKET (2026-2040) (USD MILLION) 149
Figure 64 AUSTRALIA MHEALTH MARKET (2020-2025) (USD MILLION) 150
Figure 65 AUSTRALIA MHEALTH MARKET (2026-2040) (USD MILLION) 151
Figure 66 SOUTH KOREA MHEALTH MARKET (2020-2025) (USD MILLION) 152
Figure 67 SOUTH KOREA MHEALTH MARKET (2026-2040) (USD MILLION) 153
Figure 68 REST OF ASIA PACIFIC MHEALTH MARKET (2020-2025) (USD MILLION) 154
Figure 69 REST OF ASIA PACIFIC MHEALTH MARKET (2026-2040) (USD MILLION) 155
Figure 70 MIDDLE EAST & AFRICA MHEALTH MARKET (2020-2025) (USD MILLION), BY COUNTRY 158
Figure 71 MIDDLE EAST & AFRICA MHEALTH MARKET SHARE (2023), BY COUNTRY 159
Figure 72 MIDDLE EAST & AFRICA MHEALTH MARKET (2026-2040) (USD MILLION), BY COUNTRY 161
Figure 73 MIDDLE EAST & AFRICA MHEALTH MARKET SHARE (2040), BY COUNTRY 162
Figure 74 SAUDI ARABIA MHEALTH MARKET (2020-2025) (USD MILLION) 163
Figure 75 SAUDI ARABIA MHEALTH MARKET (2026-2040) (USD MILLION) 164
Figure 76 SOUTH AFRICA MHEALTH MARKET (2020-2025) (USD MILLION) 165
Figure 77 SOUTH AFRICA MHEALTH MARKET (2026-2040) (USD MILLION) 166
Figure 78 REST OF MEA MHEALTH MARKET (2020-2025) (USD MILLION) 167
Figure 79 REST OF MEA MHEALTH MARKET (2026-2040) (USD MILLION) 168
Figure 80 LATIN AMERICA MHEALTH MARKET (2020-2025) (USD MILLION), BY COUNTRY 170
Figure 81 LATIN AMERICA MHEALTH MARKET SHARE (2023), BY COUNTRY 171
Figure 82 LATIN AMERICA MHEALTH MARKET (2026-2040) (USD MILLION), BY COUNTRY 172
Figure 83 LATIN AMERICA MHEALTH MARKET SHARE (2040), BY COUNTRY 174
Figure 84 BRAZIL MHEALTH MARKET (2020-2025) (USD MILLION) 175
Figure 85 BRAZIL MHEALTH MARKET (2026-2040) (USD MILLION) 176
Figure 86 ARGENTINA MHEALTH MARKET (2020-2025) (USD MILLION) 177
Figure 87 ARGENTINA MHEALTH MARKET (2026-2040) (USD MILLION) 178
Figure 88 REST OF LATIN AMERICA MHEALTH MARKET (2020-2025) (USD MILLION) 179
Figure 89 REST OF LATIN AMERICA MHEALTH MARKET (2026-2040) (USD MILLION) 180

Global mHealth Market Segmentation

By Offering

  • mHealth Applications and Software
  • Connected mHealth Devices
  • mHealth Services

By mHealth Application Type

  • Medical and Clinical Applications
  • Wellness and Preventive Health Applications

By Connected Device Form Factor

  • Wearable Devices
  • Handheld and Portable Devices
  • Smartphone- and Tablet-Connected Accessories
  • Connected Home Health Devices
  • Connected Medication Management Devices
  • Connected Implantable Devices

By Monitoring and Measurement Function

  • Single-Parameter Monitoring
  • Multi-Parameter Monitoring

By Primary Clinical Use Case

  • Health Promotion and Disease Prevention
  • Risk Assessment and Early Screening
  • Diagnosis and Clinical Decision Support
  • Continuous and Intermittent Patient Monitoring
  • Treatment and Therapeutic Intervention
  • Medication Management and Adherence
  • Rehabilitation and Recovery Management
  • Post-Treatment Follow-Up
  • Patient Education and Self-Management
  • Clinical Communication and Care Coordination
  • Emergency Detection and Response
  • Public-Health Surveillance and Population Management

By Disease and Therapeutic Area

  • Cardiovascular Diseases
  • Diabetes and Metabolic Disorders
  • Respiratory Diseases
  • Mental and Behavioral Health Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal and Pain Disorders
  • Women’s and Reproductive Health
  • Renal and Urological Diseases
  • Gastrointestinal Diseases
  • Infectious Diseases
  • Dermatological Diseases
  • Ophthalmic Disorders
  • Rare Diseases
  • Other Disease and Therapeutic Areas

By Primary User

  • Patients and Consumers
  • Physicians
  • Nurses
  • Pharmacists
  • Physiotherapists and Rehabilitation Professionals
  • Behavioral and Mental Health Professionals
  • Dietitians and Nutrition Professionals
  • Caregivers and Family Members
  • Community Health Workers
  • Emergency Medical Personnel
  • Clinical Researchers
  • Healthcare Administrative Personnel

By Customer Type

  • Direct-to-Consumer Customers
  • Healthcare Providers
  • Health Insurance Companies and Payers
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Employers and Corporate Wellness Providers
  • Government and Public-Health Organizations
  • Research Institutes and Academic Organizations
  • Non-Governmental and Humanitarian Organizations

By Care Setting

  • Home-Based Care
  • Hospitals
  • Ambulatory Clinics and Physician Offices
  • Diagnostic and Imaging Centers
  • Pharmacies and Retail Health Settings
  • Rehabilitation Centers
  • Long-Term Care and Assisted-Living Facilities
  • Community and Field-Based Healthcare
  • Workplace and Corporate Health Settings
  • Emergency and Prehospital Settings

By Deployment Model

  • Cloud-Based mHealth Solutions
  • On-Device and Edge-Based mHealth Solutions
  • On-Premises Enterprise mHealth Solutions
  • Hybrid mHealth Solutions

By Delivery Model

  • Business-to-Consumer
  • Business-to-Business
  • Business-to-Business-to-Consumer
  • Government-to-Citizen

By Primary Revenue Model

  • Subscription-Based Model
  • One-Time Application or Software Licensing
  • Pay-Per-Consultation or Pay-Per-Use
  • Connected-Device Sales and Bundled Services
  • Provider-, Payer- or Employer-Sponsored Access
  • Advertising and Lead-Generation Model
  • Data Analytics and Insights Licensing
  • Public Funding and Government Contract Model

By Primary Connectivity Technology

  • Bluetooth and Bluetooth Low Energy
  • Cellular Connectivity
  • Wi-Fi
  • Near-Field Communication
  • Low-Power Wide-Area Networks
  • Satellite Connectivity
  • Multi-Connectivity Solutions

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Key Players in the Global mHealth Market

The Global mHealth Market report provides company profiles covering company details, financial performance, product portfolios, key regions of operation, major competitors, subsidiaries, and recent developments such as mergers, acquisitions, partnerships, and product launches.

Connected Devices, Wearables and Medical Monitoring Companies

  • Apple Inc.
  • Alphabet Inc. (Google/Fitbit)
  • Samsung Electronics Co., Ltd.
  • Huawei Technologies Co., Ltd.
  • Xiaomi Corporation
  • Garmin Ltd.
  • Oura Health Oy
  • WHOOP, Inc.
  • Withings
  • Zepp Health Corporation
  • Polar Electro Oy
  • Abbott Laboratories
  • Dexcom, Inc.
  • Medtronic plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Senseonics Holdings, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ypsomed Holding AG
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Boston Scientific Corporation
  • Masimo Corporation
  • OMRON Healthcare Co., Ltd.
  • iRhythm Technologies, Inc.
  • ResMed Inc.
  • ZOLL Medical Corporation
  • BioIntelliSense, Inc.
  • VitalConnect, Inc.
  • Empatica Inc.
  • Sibel Health, Inc.
  • AliveCor, Inc.
  • Eko Health, Inc.
  • Butterfly Network, Inc.
  • Clarius Mobile Health Corp.
  • TytoCare Ltd.
  • Healthy.io Ltd.
  • Binah.ai Ltd.
  • Qompium NV
  • Aktiia SA
  • Biobeat Technologies Ltd.
  • CardiacSense Ltd.
  • Corsano Health B.V.
  • SmartCardia SA
  • LifeSignals, Inc.
  • Vivalink, Inc.
  • Biofourmis, Inc.
  • Huma Therapeutics Limited
  • Current Health
  • Others

Telehealth and Mobile Virtual-Care Companies

  • Teladoc Health, Inc.
  • American Well Corporation
  • Included Health, Inc.
  • Doximity, Inc.
  • Amazon One Medical
  • Hims & Hers Health, Inc.
  • K Health, Inc.
  • HealthTap, Inc.
  • eVisit, Inc.
  • MDLIVE Inc.
  • Doctolib SAS
  • Kry International AB (Livi)
  • Docplanner Group
  • Practo Technologies Pvt. Ltd.
  • Halodoc
  • Doctor Anywhere Pte. Ltd.
  • Ping An Healthcare and Technology Company Limited
  • JD Health International Inc.
  • Alibaba Health Information Technology Limited
  • Maven Clinic Co.
  • Others

Chronic Disease Management and Digital Therapeutics Companies

  • Omada Health, Inc.
  • Virta Health Corp.
  • DarioHealth Corp.
  • Welldoc, Inc.
  • Lark Technologies, Inc.
  • Noom, Inc.
  • Hinge Health, Inc.
  • Sword Health Technologies, Inc.
  • Kaia Health Software GmbH
  • Sidekick Health
  • HelloBetter
  • Big Health Ltd.
  • Click Therapeutics, Inc.
  • Virtual Therapeutics
  • WELT Corp.
  • Others

Mental and Behavioral mHealth Companies

  • Headspace Health
  • Calm.com, Inc.
  • Talkspace, Inc.
  • Spring Health
  • Wysa Ltd.
  • Others

Remote Patient Monitoring and Care-Management Companies

  • Cadence Solutions
  • Health Recovery Solutions, Inc.
  • CoachCare
  • Validic, Inc.
  • Datos Health
  • Rimidi, Inc.
  • Luscii Healthtech B.V.
  • Doccla Ltd.
  • CareSimple, Inc.
  • Veta Health LLC
  • Others

Download Sample Request Form

Loading
Your message has been sent. Thank you!

Make an Inquiry

Loading
Your message has been sent. Thank you!

Ask for Discount

Loading
Your message has been sent. Thank you!
Frequently Asked Questions

Frequently Asked Questions

What is the size of the Global mHealth Market?

The Global mHealth Market was valued at USD 120,852.77 million in 2025 and is projected to reach USD 801,216.49 million by 2040, expanding at a compound annual growth rate of 13.44% from 2025 to 2040.

What factors are driving the growth of the Global mHealth Market?

The market is growing due to increasing smartphone penetration, rising adoption of mobile healthcare applications, expanding use of connected medical devices, and growing demand for remote patient monitoring and virtual healthcare services.

How is the Global mHealth Market segmented by offering?

Based on offering, the Global mHealth Market is segmented into mHealth applications and software, connected mHealth devices, and mHealth services.

What major segments are covered in the Global mHealth Market report?

The report covers the market by offering, mHealth application type, connected device form factor, monitoring and measurement function, primary clinical use case, disease and therapeutic area, primary user, customer type, care setting, deployment model, delivery model, revenue model, connectivity technology, and region.

Who are the key players in the Global mHealth Market?

Key players operating in the Global mHealth Market include Apple Inc., Alphabet Inc. (Google/Fitbit), Samsung Electronics Co., Ltd., Abbott Laboratories, Dexcom, Inc., Medtronic plc, Koninklijke Philips N.V., Teladoc Health, Inc., Omada Health, Inc., Headspace Health, and other connected-health, telehealth, digital-therapeutics, and remote-monitoring companies.

<1-- -->